Bioaffinity Technologies Stock Technical Analysis
| BIAF Stock | USD 1.15 0.08 7.48% |
As of the 18th of February 2026, BioAffinity Technologies shows the Coefficient Of Variation of (7,491), standard deviation of 6.56, and insignificant Risk Adjusted Performance. bioAffinity Technologies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm bioAffinity Technologies treynor ratio, as well as the relationship between the value at risk and skewness to decide if bioAffinity Technologies is priced correctly, providing market reflects its regular price of 1.15 per share. Given that BioAffinity Technologies is a hitting penny stock territory we recommend to closely look at its jensen alpha.
BioAffinity Technologies Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as BioAffinity, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BioAffinityBioAffinity | Build AI portfolio with BioAffinity Stock |
Can Biotechnology industry sustain growth momentum? Does BioAffinity have expansion opportunities? Factors like these will boost the valuation of BioAffinity Technologies. Projected growth potential of BioAffinity fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating BioAffinity Technologies demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
The market value of bioAffinity Technologies is measured differently than its book value, which is the value of BioAffinity that is recorded on the company's balance sheet. Investors also form their own opinion of BioAffinity Technologies' value that differs from its market value or its book value, called intrinsic value, which is BioAffinity Technologies' true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because BioAffinity Technologies' market value can be influenced by many factors that don't directly affect BioAffinity Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between BioAffinity Technologies' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BioAffinity Technologies should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, BioAffinity Technologies' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
BioAffinity Technologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioAffinity Technologies' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioAffinity Technologies.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in BioAffinity Technologies on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding bioAffinity Technologies or generate 0.0% return on investment in BioAffinity Technologies over 90 days. BioAffinity Technologies is related to or competes with Artelo Biosciences, GT Biopharma, Mobile Health, WORK Medical, Psyence Biomedical, Revelation Biosciences, and Protagenic Therapeutics. bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targete... More
BioAffinity Technologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioAffinity Technologies' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess bioAffinity Technologies upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 32.32 | |||
| Value At Risk | (9.04) | |||
| Potential Upside | 11.4 |
BioAffinity Technologies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioAffinity Technologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioAffinity Technologies' standard deviation. In reality, there are many statistical measures that can use BioAffinity Technologies historical prices to predict the future BioAffinity Technologies' volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.40) | |||
| Treynor Ratio | (0.06) |
BioAffinity Technologies February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.05) | |||
| Mean Deviation | 4.87 | |||
| Coefficient Of Variation | (7,491) | |||
| Standard Deviation | 6.56 | |||
| Variance | 43.08 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.40) | |||
| Treynor Ratio | (0.06) | |||
| Maximum Drawdown | 32.32 | |||
| Value At Risk | (9.04) | |||
| Potential Upside | 11.4 | |||
| Skewness | (0.25) | |||
| Kurtosis | 0.8516 |
bioAffinity Technologies Backtested Returns
bioAffinity Technologies secures Sharpe Ratio (or Efficiency) of -0.0133, which signifies that the company had a -0.0133 % return per unit of risk over the last 3 months. bioAffinity Technologies exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioAffinity Technologies' insignificant Risk Adjusted Performance, standard deviation of 6.56, and Coefficient Of Variation of (7,491) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.77, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, BioAffinity Technologies will likely underperform. At this point, bioAffinity Technologies has a negative expected return of -0.0876%. Please make sure to confirm BioAffinity Technologies' treynor ratio, skewness, rate of daily change, as well as the relationship between the value at risk and accumulation distribution , to decide if bioAffinity Technologies performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.79 |
Good predictability
bioAffinity Technologies has good predictability. Overlapping area represents the amount of predictability between BioAffinity Technologies time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of bioAffinity Technologies price movement. The serial correlation of 0.79 indicates that around 79.0% of current BioAffinity Technologies price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.79 | |
| Spearman Rank Test | 0.75 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
BioAffinity Technologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
bioAffinity Technologies Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of bioAffinity Technologies volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About BioAffinity Technologies Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of bioAffinity Technologies on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of bioAffinity Technologies based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on bioAffinity Technologies price pattern first instead of the macroeconomic environment surrounding bioAffinity Technologies. By analyzing BioAffinity Technologies's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of BioAffinity Technologies's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to BioAffinity Technologies specific price patterns or momentum indicators. Please read more on our technical analysis page.
BioAffinity Technologies February 18, 2026 Technical Indicators
Most technical analysis of BioAffinity help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BioAffinity from various momentum indicators to cycle indicators. When you analyze BioAffinity charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.05) | |||
| Mean Deviation | 4.87 | |||
| Coefficient Of Variation | (7,491) | |||
| Standard Deviation | 6.56 | |||
| Variance | 43.08 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.40) | |||
| Treynor Ratio | (0.06) | |||
| Maximum Drawdown | 32.32 | |||
| Value At Risk | (9.04) | |||
| Potential Upside | 11.4 | |||
| Skewness | (0.25) | |||
| Kurtosis | 0.8516 |
BioAffinity Technologies February 18, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as BioAffinity stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 22,412 | ||
| Daily Balance Of Power | 0.53 | ||
| Rate Of Daily Change | 1.07 | ||
| Day Median Price | 1.11 | ||
| Day Typical Price | 1.12 | ||
| Price Action Indicator | 0.08 |
Complementary Tools for BioAffinity Stock analysis
When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |